The accumulation of the cellular labile iron pool (LIP) resulting from the inhibition of divalent metal transporter 1 (DMT1) can trigger ferroptosis, leading to the elimination of breast cancer stem cells and the reversal of multidrug resistance [57]. This evidence concerns the gene SLC11A2 and breast cancer.